Lawsuit seeks access to data from hepatitis C drug trialBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h3564 (Published 30 June 2015) Cite this as: BMJ 2015;350:h3564
- Michael McCarthy
Two health advocacy groups have filed suit to compel the US Food and Drug Administration to release clinical trial data submitted to the agency for the approval of the hepatitis C drugs sofosbuvir and sofosbuvir with ledipasvir. The plaintiffs also seek all FDA records relating to the clinical trials and correspondence between the agency and the US Department of Health and Human Services with companies developing the drugs.
The suit, which was brought by the Treatment Action Group, an HIV and AIDS advocacy group, and the Global Health Justice Partnership, an initiative of the Yale Law School and School of Public Health, was filed in US District Court District of Connecticut on 25 June.1
The plaintiffs contended that an independent review of the data was needed because both …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial